153 related articles for article (PubMed ID: 31111543)
1. DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease.
Wen KW; Umetsu SE; Goldblum JR; Gill RM; Kim GE; Joseph NM; Rabinovitch PS; Kakar S; Lauwers GY; Choi WT
Histopathology; 2019 Oct; 75(4):578-588. PubMed ID: 31111543
[TBL] [Abstract][Full Text] [Related]
2. Utility of DNA Flow Cytometric Analysis of Paraffin-embedded Tissue in the Risk Stratification and Management of 'Indefinite for dysplasia' in Patients With Inflammatory Bowel Disease.
Wen KW; Rabinovitch PS; Wang D; Huang D; Mattis AN; Choi WT
J Crohns Colitis; 2019 Mar; 13(4):472-481. PubMed ID: 30423034
[TBL] [Abstract][Full Text] [Related]
3. Hypermucinous, Goblet Cell-Deficient and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
Choi WT; Salomao M; Zhao L; Alpert L; Setia N; Liao X; Drage MG; Westerhoff M; Cheng J; Lauwers GY; Ko HM
J Crohns Colitis; 2022 Jan; 16(1):98-108. PubMed ID: 34232295
[TBL] [Abstract][Full Text] [Related]
4. Non-conventional dysplasia in inflammatory bowel disease is more frequently associated with advanced neoplasia and aneuploidy than conventional dysplasia.
Lee H; Rabinovitch PS; Mattis AN; Lauwers GY; Choi WT
Histopathology; 2021 May; 78(6):814-830. PubMed ID: 33155325
[TBL] [Abstract][Full Text] [Related]
5. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
[TBL] [Abstract][Full Text] [Related]
6. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
[TBL] [Abstract][Full Text] [Related]
7. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
8. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and risk stratification of Barrett's dysplasia by flow cytometric DNA analysis of paraffin-embedded tissue.
Choi WT; Tsai JH; Rabinovitch PS; Small T; Huang D; Mattis AN; Kakar S
Gut; 2018 Jul; 67(7):1229-1238. PubMed ID: 28642331
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
Montgomery E; Bronner MP; Goldblum JR; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Toledano AY; Shyr Y; Washington K
Hum Pathol; 2001 Apr; 32(4):368-78. PubMed ID: 11331953
[TBL] [Abstract][Full Text] [Related]
11. DNA flow cytometric analysis of paraffin-embedded tissue for the diagnosis of malignancy in bile duct biopsies.
Lee H; Rabinovitch PS; Mattis AN; Kakar S; Choi WT
Hum Pathol; 2020 May; 99():80-87. PubMed ID: 32272125
[TBL] [Abstract][Full Text] [Related]
12. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
14. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
Thomas T; Nair P; Dronfield MW; Mayberry JF
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
16. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
[TBL] [Abstract][Full Text] [Related]
17. The significance of "indefinite for dysplasia" grading in Barrett metaplasia.
Younes M; Lauwers GY; Ertan A; Ergun G; Verm R; Bridges M; Woods K; Meriano F; Schmulen C; Johnson C; Barroso A; Schwartz J; McKechnie J; Lechago J
Arch Pathol Lab Med; 2011 Apr; 135(4):430-2. PubMed ID: 21466357
[TBL] [Abstract][Full Text] [Related]
18. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
19. Inter-observer and intra-observer variability in the diagnosis of dysplasia in patients with inflammatory bowel disease: correlation of pathological and endoscopic findings.
Allende D; Elmessiry M; Hao W; DaSilva G; Wexner SD; Bejarano P; Berho M; Al-Qadasi M
Colorectal Dis; 2014 Sep; 16(9):710-8; discussion 718. PubMed ID: 24836541
[TBL] [Abstract][Full Text] [Related]
20. Risk for colorectal neoplasia in patients with inflammatory bowel disease and mucosa indefinite for dysplasia.
Lai KK; Horvath B; Xie H; Wu X; Lewis BL; Pai RK; Plesec T; Patil DT; Gordon IO; Wang Y; Shen B; Goldblum JR; Liu X
Inflamm Bowel Dis; 2015 Feb; 21(2):378-84. PubMed ID: 25569733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
